Intech Biopharm Ltd Financial Flexibility Index
Intech Biopharm Ltd financial flexibility index. Intech Biopharm Ltd (6461) has a Financial Flexibility Index of -0.06x as of March 2026. Free cash flow of NT$-75.16 Million (operating CF NT$-84.50 Million minus capex NT$9.33 Million) represents 0% of total liabilities (NT$1.34 Billion).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Intech Biopharm Ltd (2017–2025)
Financial flexibility index of Intech Biopharm Ltd from 2017 to 2025. Historical Financial Flexibility Index trend for Intech Biopharm Ltd across 9 annual periods. Explore 6461 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Intech Biopharm Ltd Financial Flexibility Index by Year (2017–2025)
Intech Biopharm Ltd financial flexibility index by year from 2017 to 2025. Year-by-year free cash flow to debt coverage for Intech Biopharm Ltd. For the full cash flow conversion analysis, see Intech Biopharm Ltd (6461) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.24x | NT$-297.12 Million | NT$-361.13 Million | NT$1.25 Billion | ▼ -66.6% |
| 2024 | -0.14x | NT$-225.59 Million | NT$-269.22 Million | NT$1.58 Billion | ▼ -26.6% |
| 2023 | -0.11x | NT$-173.93 Million | NT$-204.13 Million | NT$1.54 Billion | ▲ +4.6% |
| 2022 | -0.12x | NT$-179.39 Million | NT$-190.39 Million | NT$1.52 Billion | ▲ +16.7% |
| 2021 | -0.14x | NT$-179.30 Million | NT$-200.61 Million | NT$1.26 Billion | ▼ -53.8% |
| 2020 | -0.09x | NT$-119.22 Million | NT$-167.38 Million | NT$1.29 Billion | ▲ +30.6% |
| 2019 | -0.13x | NT$-137.79 Million | NT$-189.09 Million | NT$1.04 Billion | ▼ -379.3% |
| 2018 | -0.03x | NT$-28.41 Million | NT$-232.43 Million | NT$1.02 Billion | ▼ -121.8% |
| 2017 | 0.13x | NT$112.97 Million | NT$-145.29 Million | NT$887.48 Million | — |